GLOW Triple Peptide (BPC + TB + GHK)
GHH Pharma Grade
The Triple Aesthetic & Repair Stack

GLOW Triple Peptide (BPC + TB + GHK)

GHH signature skin & beauty stack — regeneration, glow & repair

AED 1,466.25
Physician Required

GLOW Triple Peptide (BPC-157 + TB-500 + GHK-Cu) is GHH's signature aesthetic and regenerative combination. These three peptides work synergistically on complementary pathways: BPC-157 drives systemic healing and growth factor upregulation; TB-500 promotes cell migration and anti-inflammatory repair; GHK-Cu stimulates collagen synthesis and skin rejuvenation. Together, they create a comprehensive tissue repair, skin, and hair restoration protocol.

💉
Injectable / Oral
Administration
⏱️
2–4 weeks
First Results
🔄
8–12 week cycles with 4-week break
Cycle Length
🎯

Clinical Uses

What conditions & goals this peptide addresses

Comprehensive skin rejuvenation & anti-aging
Hair loss & density restoration
Wound healing & scar reduction
Post-aesthetic procedure recovery
Collagen & elastin optimisation
Athletic recovery with skin benefits
Systemic inflammation reduction

Key Benefits

The measurable outcomes you can expect

Triple synergistic action on tissue repair
GHK-Cu boosts collagen I, III, IV production
BPC-157 enhances angiogenesis and healing
TB-500 accelerates cell migration and recovery
Reduces inflammation on all tissue levels
Improves skin firmness, elasticity, and texture
Promotes hair follicle growth and density
🔬

How It Works — Mechanism of Action

The precise biology behind this peptide's effects

BPC-157 upregulates VEGF and growth hormone receptors while suppressing inflammatory cytokines. TB-500 sequesters actin, enabling rapid cell migration to damaged tissue. GHK-Cu delivers copper to fibroblasts, activating 4,000+ genes in skin repair and collagen synthesis. The triple combination addresses all three phases of tissue repair: inflammation, proliferation, and remodelling.

Administration Guide

Subcutaneous injection. Combine in the same syringe or inject separately. Can also use topical GHK-Cu for skin-specific effect while injecting BPC-157/TB-500 systemically.

💊

Dosage Protocol

GHH physician-guided dosing guidelines

BPC-157: 250–500 mcg + TB-500: 2.5–5 mg + GHK-Cu: 1–2 mg. Inject daily (BPC-157) and twice weekly (TB-500, GHK-Cu). Run for 8–12 weeks.

🔄
Cycle Length
8–12 week cycles with 4-week break
🧊
Storage
Each component: Refrigerate 2–8°C after reconstitution.

When to Expect Results

A realistic timeline from first dose to full effect

Skin texture improvement: 2–4 weeks. Hair density: 6–12 weeks. Full aesthetic transformation: 12–16 weeks.

Day 1–7
Week 2–4
Week 4–8
Week 8–16
⚠️

Side Effects

What to watch for and how common they are

Excellent individual safety profiles for all three components. Combined: no known adverse interactions. Injection site reactions possible.

🚫

Contraindications

Who should not use this peptide

Active cancer (BPC-157/TB-500 are pro-angiogenic). Pregnancy. Wilson's disease (GHK-Cu).

Best Stacked With

Peptide synergies recommended by GHH physicians

Epithalon for anti-aging enhancement CJC-1295/Ipamorelin for GH-driven skin collagen KPV for inflammatory skin conditions

Compare this peptide side-by-side

See how it stacks up against other protocols

🩺

Ready to Start Your GLOW Protocol?

All peptide protocols require a physician consultation and blood work. Our licensed UAE physicians will craft a personalised plan for you.

The Science of Peptides

Understanding Your Body's Language

Peptides are not exotic foreign chemicals — they are the precise molecular signals your body has evolved to use for billions of years. Here's what you need to know.

🔭
"Peptides don't change who you are — they restore who you were designed to be."

— German Health Hub Clinical Philosophy

All peptides require UAE licensed physician review and mandatory blood work before dispensing. Information presented is for educational purposes only and does not constitute medical advice. Individual results may vary. Peptides are prescribed and dispensed under strict medical supervision by German Health Hub's licensed clinical team.